Oncolytics Biotech Inc.
4660 La Jolla Village Drive
Suite 850
San Diego
CA
92122
United States
Website: http://www.oncolyticsbiotech.com/
447 articles with Oncolytics Biotech Inc.
-
Oncolytics Biotech Announces 2017 First Quarter Results
5/5/2017
-
Oncolytics Biotech Announces Details Of 2017 Annual Meeting Of Shareholders
4/27/2017
-
Oncolytics Biotech Announces Registration Pathway And Clinical Development Plan
4/12/2017
-
Oncolytics Biotech’s REOLYSIN More Than Doubles Overall Survival in Patients With Mutated p53 Metastatic Breast Cancer
4/5/2017
-
Oncolytics Biotech Inc.'s REOLYSIN Provides Statistically Significant Improvement In Overall Survival In Canadian Cancer Trials Group Sponsored Randomized Phase II Study In Metastatic Breast Cancer
4/3/2017
-
Oncolytics Biotech Inc. Enters Into First-In-Class Collaboration With Myeloma UK And Celgene Using REOLYSIN In Combination With Imnovid Or Revlimid In Patients With Myeloma
3/16/2017
-
Oncolytics Biotech Inc. Announces 2016 Year-End Results
3/10/2017
-
Oncolytics Biotech Inc. Release: Company Appoints Dr. Matt Coffey To The Role Of President And CEO
1/19/2017
-
Oncolytics Biotech Inc. Announces Change To Board Of Directors
12/7/2016
-
Oncolytics Biotech Inc. Collaborators Present Initial Results From REO 019 Study In Multiple Myeloma Combining REOLYSIN, Bortezomib And Dexamethasone At The American Society of Hematology Annual Meeting
12/6/2016
-
Oncolytics Biotech Inc. Announces Appointment Of New Chief Medical Officer
11/10/2016
-
Oncolytics Biotech Inc. Announces 2016 Third Quarter Results
11/2/2016
-
Oncolytics Biotech Inc. Announces Participation In The 4th Annual Immuno-Oncology Summit
8/30/2016
-
MEDIA ADVISORY - Oncolytics Biotech Inc. Announces Participation In The Canaccord Genuity 36th Annual Growth Conference
8/11/2016
-
Oncolytics Biotech Inc. Reports Additional Data From Randomized Phase II Study Of REOLYSIN In Non-Small Cell Lung Cancer
8/10/2016
-
Oncolytics Biotech Inc. Announces 2016 Second Quarter Results
8/4/2016
-
Oncolytics Biotech Inc. Announces Phase 2 Study In Female Patients With Colorectal Cancer Metastatic To The Liver
6/29/2016
-
Oncolytics Biotech Inc. Announces Voting Results From Its Annual Meeting Of Shareholders
5/6/2016
-
Oncolytics Biotech Inc. Announces 2016 First Quarter Results
5/6/2016
-
Oncolytics Biotech Inc. Announces Presentation Of REOLYSIN Preclinical Research At The 2016 ASGCT Annual Meeting
5/5/2016